Cardio Diagnostics Holdings Depreciation & Amortization Growth & History (CDIO)

Cardio Diagnostics Holdings's depreciation and amortization was $65,233 for fiscal 2025.

View full Cardio Diagnostics Holdings company overview

Cardio Diagnostics Holdings annual depreciation and amortization history

Cardio Diagnostics Holdings annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$65,233$45,495+230.49%
20242024-12-31$19,738$556+2.90%
20232023-12-31$19,182$3,182+19.89%
20222022-12-31$16,000$00.00%
20212021-12-31$16,000

Cardio Diagnostics Holdings depreciation and amortization trends

Between the periods ended 2021-12-31 and 2025-12-31, Cardio Diagnostics Holdings's depreciation and amortization increased from $16,000 to $65,233, a change of $49,233. The latest reported quarter, Q2 2026, shows $5,593.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Cardio Diagnostics Holdings source filings ↗

Community posts

It’s quiet here.

No posts about CDIO yet. Start the conversation.

Write the first post